When drugs are trialed in patients, they move into a clinical setting in which the busy routine care of patients, rath...
Tokyo: New Jersey-headquartered Catalent Pharma Solutions, the leading global provider of advanced delivery technologies...
Australia's strong history of quality and experience in clinical research is well known, and whilst being a comparativ...
OxOnc Development LP has announced that Study OO-1201, a phase II open-label, single-arm study of crizotinib in East Asi...
Over the past four years, BioSpectrum Asia in association with CyberMedia Research (CMR) has been capturing the key br...
Singapore: Australian company Cogstate has earned overall revenue of $6.14 million and a net loss of $0.49 million in th...
Singapore: Parexel International has acquired all of the outstanding equity securities of Liquent, a leading global prov...
Singapore: Monitoring a clinical study is an important challenge faced by local as well as global CRO where the sponsor ...
Singapore: Quintiles and Muscular Dystrophy Association (MDA) have formed a partnership to develop and implement the US ...
Singapore: Australia based Novotech has strengthened its Hong Kong operation with expansion of its manpower base. The c...
Singapore: In a study that analysed reports from large clinical trials (more than 500 participants), registered on Clini...
Singapore: Cardiologists at the University of Rochester Medical Center, US, are launching a new study in an effort to im...
Singapore: European Medicines Agency (EMA) has been ordered by the General Court of the European Union not to provide do...
Over the past decade the world's centre of economic gravity has shifted from US and Europe to Asia at a speed and scale ...
Singapore: Pharma and biotech R&D service provider, WuXi PharmaTech, has acquired XenoBiotic Laboratories, a contrac...
INC Research Holdings Inc, a leading, global phase I to IV contract research organization (CRO), has announced the reloc...
Singapore: Clinical trials registered: 5,276 Growth in China's clinical research sector is projected to be around 20 per...
Singapore: Days after cancelling around 40 ongoing clinical trials in India, the National Institutes of Health (NIH) has...
